Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Nano Lett ; 22(24): 9958-9963, 2022 Dec 28.
Artículo en Inglés | MEDLINE | ID: mdl-36511687

RESUMEN

Single-crystal nanowires are of broad interest for applications in nanotechnology. However, such wires are subject to both the Rayleigh-Plateau instability and an ovulation process that are expected to lead to their break up into particle arrays. Single crystal Ru nanowires were fabricated with axes lying along different crystallographic orientations. Wires bound by equilibrium facets along their length did not break up through either a Rayleigh-Plateau or ovulation process, while wires with other orientations broke up through a combination of both. Mechanistic insight is provided using a level-set simulation that accounts for strongly anisotropic surface energies, providing a framework for design of morphologically stable nanostructures.

2.
Bioanalysis ; 8(10): 1035-49, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-27095045

RESUMEN

AIM: A sensitive generic LC-MS/MS method for hIgG1 quantification in cynomolgus monkey serum using mass spectrometric immunoassay disposable automation research tips (MSIA-D.A.R.T.'S™) is reported. RESULTS: The hIgG1 was captured with a biotinylated mouse anti-hIgG antibody (50.0 µg/ml) targeting the fragment crystallizable (Fc) region. Elution from the streptavidin-coated MSIA-D.A.R.T.'s was conducted with 0.4% trifluoroacetic acid in water. The method was selective and linear from 10.0 to 1000 ng/ml using 100 µl of serum. The method was evaluated regarding accuracy, precision, carry-over, dilution, auto-sampler stability and applied for the determination of hIgG1 concentration in monkey serum after intravitreal administration. CONCLUSION: The present assay is suitable for quantitative analysis of hIgG1-based therapeutic proteins in monkey serum at low levels.


Asunto(s)
Inmunoensayo/métodos , Inmunoglobulina G/sangre , Macaca fascicularis/sangre , Espectrometría de Masas en Tándem/métodos , Animales , Anticuerpos Antiidiotipos/química , Biotinilación , Cromatografía Liquida/métodos , Inmunoglobulina G/análisis , Límite de Detección , Ratones
3.
Appl Opt ; 55(8): 2071-8, 2016 Mar 10.
Artículo en Inglés | MEDLINE | ID: mdl-26974804

RESUMEN

Infrared-absorbing gold black has been selectively patterned onto the active surfaces of a vanadium-oxide-based infrared bolometer array. Patterning by metal lift-off relies on protection of the fragile gold black with an evaporated oxide, which preserves much of gold black's high absorptance. This patterned gold black also survives the dry-etch removal of the sacrificial polyimide used to fabricate the air-bridge bolometers. For our fabricated devices, infrared responsivity is improved 22% in the long-wave IR and 70% in the mid-wave IR by the gold black coating, with no significant change in detector noise, using a 300°C blackbody and 80 Hz chopping rate. The increase in the time constant caused by the additional mass of gold black is ∼15%.

4.
Cytokine ; 39(3): 184-91, 2007 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17822917

RESUMEN

Activators of peroxisome proliferator-activated receptor (PPAR)-gamma are anti-inflammatory and have been proposed as therapeutic agents for the treatment of Th1-type inflammatory diseases. We report that nanomolar concentrations of rosiglitazone enhance the production of IL-10 from activated human mature monocyte-derived dendritic cells. Also, rosiglitazone specifically induces the production of IL-10 from TCR-activated human CD4+ T cells and that this effect is PPAR-gamma-dependent. We also demonstrate for the first time the presence of a functional PPAR response element (PPRE) in the human IL-10 promoter region. Finally we show that rosiglitazone can induce IL-10 in combination with 1,25 alpha-dihydroxyvitamin D3 to a greater extent than each treatment alone. In summary our findings demonstrate that IL-10 is upregulated by nanomolar TZDs in immune cells, and this may, in part, be responsible for the potential anti-inflammatory effects of PPAR-gamma in humans.


Asunto(s)
Linfocitos T CD4-Positivos/efectos de los fármacos , Células Dendríticas/efectos de los fármacos , Interleucina-10/biosíntesis , Tiazolidinedionas/farmacología , Regulación hacia Arriba/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Linfocitos T CD4-Positivos/metabolismo , Células Cultivadas , Colecalciferol/farmacología , Células Dendríticas/inmunología , Células Dendríticas/metabolismo , Relación Dosis-Respuesta a Droga , Sinergismo Farmacológico , Humanos , Interleucina-10/genética , PPAR gamma/agonistas , PPAR gamma/genética , PPAR gamma/fisiología , Regiones Promotoras Genéticas/efectos de los fármacos , Rosiglitazona , Regulación hacia Arriba/genética , Regulación hacia Arriba/inmunología
5.
J Immunol Methods ; 262(1-2): 167-80, 2002 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-11983230

RESUMEN

We describe an intracellular cytokine staining, flow cytometry based technique for quantitative and qualitative assessment of CD8+ T lymphocyte-mediated antigen specific immune responses. This adaptation of the technique first described by Suni et al. [J. Immunol. Methods, 212 (1998) 89; Cytometry, 40 (2000) 60] utilises a recombinant vaccinia expression vector to deliver the test antigen to the MHC class I processing pathway. This allows the measurement of antigen-specific CD8+ T cell responses in human subjects, irrespective of HLA type, and un-restricted to responses directed against a single peptide epitope. This method offers an advantage over the ELISPOT methods because the cells producing cytokine in the assay can be readily phenotyped, and it permits the simultaneous analysis of multiple cytokines. Finally, this technique does not require the prior establishment of autologous transformed B cell lines from patients/subjects.


Asunto(s)
Antígenos/inmunología , Linfocitos T CD8-positivos/inmunología , Inmunoensayo/métodos , Activación de Linfocitos , Presentación de Antígeno , Antígenos/administración & dosificación , Linfocitos T CD8-positivos/patología , Citocinas/análisis , Citocinas/inmunología , Sistemas de Liberación de Medicamentos , Vectores Genéticos , Antígenos de Histocompatibilidad Clase I/inmunología , Humanos , Proteínas Recombinantes/administración & dosificación , Proteínas Recombinantes/genética , Proteínas Recombinantes/inmunología , Coloración y Etiquetado , Virus Vaccinia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...